SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
1-Year Return
14.64%
This Quarter Return
-18.02%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$562M
AUM Growth
-$160M
(-22%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
319
New
49
Increased
97
Reduced
64
Closed
52
Top Buys
| 1 |
GitLab
GTLB
|
$8.95M |
| 2 |
SentinelOne
S
|
$7.05M |
| 3 |
Okta
OKTA
|
$6.7M |
| 4 |
Cloudflare
NET
|
$5.8M |
| 5 |
Confluent
CFLT
|
$5.66M |
Top Sells
| 1 |
FIVE9
FIVN
|
$14.5M |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
$11.2M |
| 3 |
Dynatrace
DT
|
$10.6M |
| 4 |
HubSpot
HUBS
|
$9.63M |
| 5 |
Elastic
ESTC
|
$9.08M |
Sector Composition
| 1 | Technology | 32.77% |
| 2 | Industrials | 11.44% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 7.36% |
| 5 | Communication Services | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
LiveRamp
RAMP
$1.82B
| $1.04M | 0.19% |
40,343
+708
| +2% | +$18.3K |
|
127
NVIDIA
NVDA
$4.18T
| $988K | 0.18% |
65,150
-310
| -0.5% | -$4.7K |
|
128
Castle Biosciences
CSTL
$670M
| $963K | 0.17% |
43,875
+3,659
| +9% | +$80.3K |
|
|
DCT
129
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $947K | 0.17% |
63,748
+3,673
| +6% | +$54.6K |
|
130
Adaptive Biotechnologies
ADPT
$1.98B
| $929K | 0.17% |
114,780
+8,288
| +8% | +$67.1K |
|
131
Quanterix
QTRX
$201M
| $927K | 0.16% |
57,249
+675
| +1% | +$10.9K |
|
132
Q2 Holdings
QTWO
$4.82B
| $876K | 0.16% |
22,704
+2,184
| +11% | +$84.3K |
|
133
CVS Health
CVS
$93.5B
| $633K | 0.11% |
6,833
| – | – |
|
134
Synopsys
SNPS
$111B
| $610K | 0.11% |
2,010
| – | – |
|
135
Bank of America
BAC
$375B
| $598K | 0.11% |
19,201
+33
| +0.2% | +$1.03K |
|
136
Elevance Health
ELV
$69.4B
| $546K | 0.1% |
1,132
-229
| -17% | -$110K |
|
137
Intuit
INTU
$186B
| $543K | 0.1% |
1,408
-2
| -0.1% | -$771 |
|
|
EGRX
138
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $533K | 0.09% |
12,000
-12,000
| -50% | -$533K |
|
139
Procter & Gamble
PG
$373B
| $527K | 0.09% |
3,664
-398
| -10% | -$57.2K |
|
140
JPMorgan Chase
JPM
$835B
| $453K | 0.08% |
4,021
-1,827
| -31% | -$206K |
|
141
MSCI
MSCI
$43.1B
| $448K | 0.08% |
1,086
| – | – |
|
142
Bristol-Myers Squibb
BMY
$95B
| $409K | 0.07% |
+5,318
| New | +$409K |
|
143
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $395K | 0.07% |
8,735
+90
| +1% | +$4.07K |
|
144
PepsiCo
PEP
$201B
| $395K | 0.07% |
2,373
-604
| -20% | -$101K |
|
145
Meta Platforms (Facebook)
META
$1.88T
| $350K | 0.06% |
+2,173
| New | +$350K |
|
146
Zoetis
ZTS
$67.9B
| $347K | 0.06% |
+2,020
| New | +$347K |
|
147
Air Products & Chemicals
APD
$64.5B
| $319K | 0.06% |
1,328
-214
| -14% | -$51.4K |
|
148
Coca-Cola
KO
$294B
| $315K | 0.06% |
5,000
| – | – |
|
149
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $293K | 0.05% |
7,192
+141
| +2% | +$5.74K |
|
150
Marsh & McLennan
MMC
$101B
| $284K | 0.05% |
1,831
-517
| -22% | -$80.2K |
|